Background/Aims: Long noncoding RNAs (lncRNAs) contribute to the development of multiple malignant tumors. Here, we focused on the biological function and underlying molecular mechanism of an lncRNA, nuclear-enriched abundant transcript 1 (NEAT1), in lung adenocarcinoma (LUAD). Methods: In vitro experiments were conducted to determine the biological effects of NEAT1 in LUAD cells. A luciferase activity reporter assay was performed to corroborate the interaction between NEAT1 and miR-193a-3p. Data from Gene Expression Omnibus (GEO), Oncomine, The Cancer Genome Atlas (TCGA), and our in-house reverse transcription quantitative PCR (RT-qPCR) were combined to examine the expression of NEAT1 and miR-193a-3p in LUAD. To further explore the regulatory mechanism of NEAT1, we searched for putative target genes of miR-193a-3p from 12 online prediction databases and determined genes positively correlated with NEAT1 as candidate targets. Furthermore, we analyzed the expression of these selected genes using data from TCGA. Results: In vitro experiments showed that knockdown of NEAT1 in LUAD cells markedly restrained cell proliferation, invasion, and migration and stimulated cell apoptosis. The dual-luciferase reporter assay demonstrated that miR-193a-3p directly targeted NEAT1 at its 3'-UTR. We then detected NEAT1 and miR-193a-3p in LUAD cells and normal lung epithelial cells and discovered high expression of NEAT1 and low expression of miR-193a-3p in LUAD cell lines. Simultaneously, the pooled results from the GEO, Oncomine, TCGA, and in-house RT-qPCR showed that the NEAT1 expression increased while the miR-193a-3p expression decreased in LUAD tissues versus normal lung tissues. Furthermore, the USF1 gene was not only upregulated in LUAD, but also positively correlated with NEAT1, suggesting that NEAT1 may function as a ceRNA to sponge miR-193a- 
Introduction
Lung cancer is the main cause of oncogenic mortality in both men and women worldwide [1, 2] . Non-small cell lung carcinoma (NSCLC), the most prevalent form of lung cancer, includes three histopathological subtypes: adenocarcinoma, squamous cell carcinoma, and large cell carcinoma [3] . Lung adenocarcinoma (LUAD) is the most common variant, accounting for nearly 40% of lung cancer cases [3, 4] . Despite improved understanding of oncogenic drivers, the potential molecular mechanism of LUAD remains unclear. Thus, investigation of the possible mechanism of LUAD pathogenesis is an urgent and challenging task.
Increasing numbers of studies have concentrated on long noncoding RNAs (lncRNAs), which may be cell-type specific RNAs that contribute to tumor onset and progression via multiple ways, including cell cycle regulation, transcriptional/post-transcriptional regulation, and DNA methylation [5] [6] [7] [8] . Nuclear-enriched abundant transcript 1 (NEAT1), a structural component of paraspeckle, plays critical roles in several malignancies, including lung cancer. Our research group has previously examined the expression of NEAT1 in NSCLC via reverse transcription quantitative PCR (RT-qPCR) [9] . The results indicated that NEAT1 was upregulated in NSCLC compared with adjacent non-tumorous tissues, with overexpressed NEAT1 strongly associated with several malignant clinical phenotypes, such as lymphatic metastasis, TNM stage, and vascular invasion. A study by Sun et al [10] . showed that NEAT1 played key roles in NSCLC by promoting the Wnt/β-catenin pathway. Accumulating studies have reported that lncRNAs, including NEAT1, exert roles in tumors by functioning as miRNA sponges or competing endogenous RNAs (ceRNAs) to interact with miRNAs. In NSCLC, NEAT1 has been demonstrated to competitively bind to miRNAs, such as miR-181a-5p and miR-98, and subsequently upregulate their target genes [11, 12] . Sun et al [13] . discovered that NEAT1 accelerated NSCLC development by acting as a ceRNA for miR-377-3p and antagonizing the inhibition of miR-377-3p on its target gene E2F3, a critical oncogene in NSCLC carcinogenesis. Similarly, the impact of NEAT1 on the miR-377-3p/E2F3 axis in NSCLC was recapitulated in a study conducted by Zhang et al [14] .. However, the understanding of the underlying role and functional mechanism of NEAT1 in LUAD is still limited. We therefore carried out this study to elucidate the possible regulatory mechanism of NEAT1 in LUAD.
In the present study, we first performed in vitro experiments to investigate the biological function of NEAT1 in LUAD. A luciferase activity assay was then conducted to verify the interaction between NEAT1 and miR-193a-3p. Microarray and RNA-seq data were mined to validate the expression of NEAT1 and miR-193a-3p in LUAD. Furthermore, the potential targets of miR-193a-3p were predicted by online tools, and bioinformatics analysis was subsequently performed to explore the active mechanism of NEAT1 in LUAD.
Materials and Methods
Cell culture and transfection Four LUAD cell lines (H1299, A549, HCC827, and Calu3), one human renal epithelial cell line (293T), and one normal lung epithelial cell line (BEAS-2B) were purchased from ScienCell Research Laboratories (Carlsbad, CA) and cultured in RPMI-1640 (Invitrogen, Carlsbad, CA) medium supplemented with 10% fetal bovine serum (Biological Industries, Beit Haemek, Israel) and 1% penicillin/streptomycin (Invitrogen). Cells were transfected with mock control, blank control, scrambled siRNAs, and NEAT1 siRNAs for in vitro experiments according to the manufacturer's instructions. After 48 hours, the transfection efficiency was verified via RT-qPCR.
Biological effects of NEAT1 on LUAD cells in cell functional experiments
We selected cell lines for further in vitro experiments based on the aforementioned RT-qPCR results. Cell viability and proliferation were detected with fluorometric detection of resorufin (CellTiter-Blue Cell Viability Assay, G8080, Promega, Madison, WI) and colorimetric tetrazolium (MTS) assay (CellTiter96 AQueous One Solution Cell Proliferation Assay G3580, Promega), respectively. Cell apoptosis was examined with Hoechst 33342 and propidium iodide (PI; Sigma-Aldrich, St. Louis, MO) double-fluorescent chromatin staining and the Apo-ONE® Homogeneous Caspase-3/7 Assay (G7790, Promega). Two reviewers independently counted the viable and apoptotic cells in 10 fields of each well under a 200× magnification microscope after Hoechst 33342/PI double-fluorescent chromatin staining at 96 hours. A wound-healing assay was conducted to monitor cell migration. Photographs of the wound were obtained at 0, 12, 24, and 48 hours to observe cell migration and calculate the wound width. The wound widths at 12, 24, and 48 hours were compared with the wound width of the blank control at 0 hours. A Transwell assay was performed to detect the effects of NEAT1 on LUAD cell invasion. Cells were independently counted in five random fields under a microscope by two investigators. All in vitro experiments were conducted as reported in preceding studies [16] [17] [18] [19] .
Validation of NEAT1 and miR-193a-3p binding based on luciferase activity
To corroborate whether NEAT1 directly binds to miR-193a-3p, a human renal cell line 293T was chosen for the luciferase activity assay due to its high transfection efficiency. The wild-type (WT) NEAT1 3'-UTR binding site of miR-193a-3p was subcloned into pGL3 Basic vector (Promega). Similarly, the WT TRAF6 3'-UTR binding site of miR-146 was also cloned into pGL3 Basic vector (Promega) as a positive control [20, 21] . WT NEAT1-3'-UTR or WT TRAF6-3'-UTR vector and miRNA mimic or negative control (NC) plasmid were then co-transfected into 293T cells. After 48 hours, the luciferase activity was determined with the Dual-Luciferase® Reporter Assay System (Promega) in accordance with the manufacturer's protocols.
Statistical analysis
All experiments were performed in triplicate, and continuous variable results are presented as the mean ± standard deviation (SD). A Student's t test or one-way analysis of variance was used for comparisons between groups. All statistical analyses were carried out using SPSS 22.0 (IBM, Armonk, NY) and GraphPad Prism v5.0 (GraphPad Software, Inc., La Jolla, CA). P<0.05 indicated statistical significance.
Clinical roles of NEAT1 and miR-193a-3p based on meta-analyses
To investigate the expression and correlation of NEAT1 and miR-193a-3p in LUAD, we performed a meta-analysis based on data from Gene Expression Omnibus (GEO; http://www.ncbi.nlm.nih.gov/geo/), Oncomine (https://www.oncomine.org/resource/main.html), The Cancer Genome Atlas (TCGA; https:// cancergenome.nih.gov/), and our in-house RT-qPCR. The following search strategies were used to retrieve eligible datasets from GEO: (lung OR pulmonary OR LC OR LUAD) AND (miRNA OR microRNA OR miR OR "non-coding RNA" OR ncRNA OR lncRNA OR "noncoding RNA" OR "non coding RNA"). The inclusion criteria were as follows: (i) available expression data of NEAT1 and miR-193a-3p; (ii) a sample size of each dataset in cancer and non-cancerous groups exceeding 3; (iii) human species; and (iv) expression data in the miRNArelated dataset for mature miR-193a-3p.
The following characteristics of each included dataset were collected: first author and published year, region, data source, platform, sample size, and expression level of NEAT1 or miR-193a-3p. The pooled standard mean difference (SMD) and corresponding 95% confidence intervals (CIs) were calculated to assess the overall expression levels of NEAT1 and miR-193a-3p in LUAD. A summary receiver operating characteristic (sROC) curve was generated to illustrate the ability of NEAT1 and miR-193a-3p expression to discriminate LUAD patients from normal controls. The heterogeneity among included studies was evaluated by the χ2-based Q test and I 2 statistic. A random-effects model was used if there was heterogeneity (I 2 >50% or P<0.05). Otherwise, a fixed-effects model would be chosen [22] . Sensitivity analysis was implemented to assess the stability of the pooled SMD. Begg's funnel plot and Egger's test were used to ascertain the possible publication bias. P>0.05 favored no publication bias.
Identification of potential targets of miR-193a-3p based on bioinformatics analysis
Potential targets of miR-193a-3p were forecasted in miRWalk 2.0 (http://zmf.umm.uni-heidelberg.de/ apps/zmf/mirwalk2/); this database contains 12 prediction algorithms (TargetScan, RNAhybrid, RNA22, PITA, Pictar2, miRWalk, Microt4, miRNAMap, miRDB, miRBridge, miRanda, and miRmap). Genes appearing in at least 8 algorithms were considered to be putative targets of miR-193a-3p. Additionally, genes positively correlated with NEAT1 were obtained from TCGA. The intersection between the predicted targets and positively correlated genes was determined. Then, we evaluated the expression levels of the overlapping genes with data from TCGA.
Results

Knockdown of NEAT1 inhibits LUAD cell proliferation and triggers cell apoptosis in vitro
To determine the biological role of NEAT1 in LUAD cell proliferation and apoptosis, we established NEAT1-knockdown cell lines (A549 and Calu3) using siRNAs, with knockdown efficiencies from 75% to 92%. Fluorometric detection of resorufin and an MTS assay showed that silencing of NEAT1 in vitro markedly arrested cell viability and proliferation in both A549 and Calu3 cells (Fig. 1 ). In addition, the effects of NEAT1 on LUAD cell apoptosis were detected by Hoechst 33342/PI double-fluorescent chromatin staining and caspase-3/7 assay. The results indicated that the apoptosis and caspase-3/7 activity of A549 and Calu3 cell lines following NEAT1 knockdown were clearly increased ( Fig. 2A-2D ). Simultaneously, we observed viable and apoptotic cells under a microscope after Hoechst 33342/PI staining at 96 hours. The results suggested that NEAT1 siRNAs apparently stimulated apoptosis and restrained viability of A549 and Calu3 cell lines (Fig. 2E) .
Knockdown of NEAT1 reduces LUAD cell invasion and migration in vitro
Next, we silenced NEAT1 in H1299 cells and subsequently examined the effect of NEAT1 on cell invasion and migration by wound-healing and Transwell assays. Our results showed that the invasion and metastasis of NEAT1-knockdown cells were markedly decreased compared with control cells (Figs. 3, 4) , suggesting that NEAT1 siRNAs impeded LUAD cell invasive and metastatic ability in vitro. 
NEAT1 directly binds to miR-193a-3p in LUAD cells
Multiple studies have demonstrated that lncRNAs could serve as ceRNAs or molecular sponges of miRNAs in multiple malignancies. To determine whether NEAT1 exerts a similar mechanism in LUAD cells, we screened miRNAs containing putative binding sites in NEAT1 with microRNA.org (http://34.236.212.39/microrna/home.do). miR-193a-3p was found to harbor multiple binding sites in NEAT1 (Fig. 5A) . Then, we examined the expression of NEAT1 and miR-193a-3p in LUAD cell lines (A549, H1299, and HCC827) and a normal (Fig. 5C ).
NEAT1 is upregulated while miR-193a-3p is downregulated in LUAD tissues based on metaanalysis
To further elucidate the expression of and correlation between NEAT1 and miR-193a-3p in LUAD, we obtained data from GEO, Oncomine, TCGA, and RT-qPCR on-file to conduct comprehensive analyses. A total of 11 records with 1405 LUAD samples and 415 non-cancerous samples were included for NEAT1 and 10 records with 402 LUAD samples and 213 non-cancerous samples for miR-193a-3p. The basic information on these studies is included in Table 1 and Table 2 . The expression of NEAT1 and miR-193a-3p in each dataset is presented as a box-scatter plot and receiver operating characteristic (ROC) curve (Figs. 6-9 ). Due to the divergences in individual studies, we then combined all of the included datasets. The pooled results showed that the expression level of NEAT1 was higher in LUAD tissues than in normal lung tissues (SMD=0.44, 95% CI=0.32- 10A ). In contrast, the expression of miR193a-3p was lower in LUAD tissues than in normal lung tissues (SMD=-0.46, 95% CI=-0.83 to -0.09, P=0.014; I 2 =58.1%, P=0.011; Fig. 10B ). Sensitivity analyses suggested that the pooled results were stable (Fig.  11 ). Begg's and Egger's tests indicated no publication bias (NEAT1: Begg's P=0.213, Egger's P=0.137; Fig. 12A ; miR-193a-3p: Begg's P=0.721, Egger's P=0.281; Fig. 12B ).
Simultaneously, sROC curves were also generated to illustrate the ability of NEAT1 and miR-193a-3p expressions to differentiate LUAD patients from normal controls. As shown in Fig. 13 , the area under the curve (AUC) for NEAT1 was 0.75 (95% CI=0.71-0.78), with a sensitivity and specificity of 0.90 (95% CI=0.76-0.96) and 0.43 (95% CI=0.25-0.63), respectively. As for miR-193a-3p, the AUC value was 0.77 (95% CI=0.73-0.80), with a sensitivity and specificity of 0.85 (95% CI=0.61-0.95) and 0.61 (95% CI=0.42-0.76), respectively.
NEAT1 may compete with USF1 for binding to miR-193a-3p as a ceRNA
Putative targets of miR-193a-3p were obtained from 12 prediction algorithms. A total of 285 genes that appeared in at least 8 algorithms were considered targets of miR-193a-3p. Simultaneously, we collected 552 genes positively correlated with NEAT1 from cBioPortal, a database that collects and processes data from TCGA. The intersection between the predicted target genes and positively correlated genes was determined (Fig. 14) . In all, six overlapping genes (PIGA, USF1, RGS12, CLEC16A, MMP19, and KHNYN) were obtained for further analyses. The expression patterns of the six genes were visualized in the form of a heatmap and box-scatter plots based on data from TCGA (Fig. 15) . According to our results, both USF1 and KHNYN were significantly upregulated in LUAD. We then predicted the binding sites of miR-193a-3p with USF1 and KHNYN and found that only the USF1 gene contained conserved miR-193a-3p binding sites (Fig.  16A) . The correlation between USF1 and NEAT1 is shown in Fig. 16B . Furthermore, the overexpression of USF1 in LUAD was confirmed by data from Oncomine (Fig. 17) . Because USF1 is a protein-coding gene, we also validated the expression of its encoded protein using data from The Human Protein Atlas database (http://www.proteinatlas. org/). We found that protein USF1 was highly expressed in LUAD tissues compared with normal lung tissues (Fig. 18) .
Discussion
Increasing studies have reported that lncRNAs, a class of RNA molecules with more than 200 nucleotides, perform complicated and critical roles in a myriad of malignant tumors at chromatin organizational, translational, and post-translational levels [23] [24] [25] [26] [27] . In-depth analysis of the exact actions and mechanisms of specific lncRNAs in tumorigenesis contributes to clinical treatment decision-making in patients with cancers.
The lncRNA NEAT1, an important structural component of paraspeckle, regulates gene transcription and translation by retaining and editing mRNA in the cell nucleus [28] [29] [30] . Multiple reports have indicated that NEAT1 is involved in several malignant tumors, such as hepatocellular carcinoma [31] , ovarian carcinoma [32] , breast cancer [33] , and endometrial carcinoma [34] . The close correlation between NEAT1 expression and NSCLC has also been investigated [11] [12] [13] [14] .
In this study, we aimed to uncover the biological function and underlying regulatory mechanism of NEAT1 in LUAD. First, we carried out in vitro experiments and found that knockdown of NEAT1 in LUAD cells markedly repressed cell proliferation, invasion, and migration and induced cell apoptosis, indicating that NEAT1 could drive LUAD development. However, one limitation should not be ignored in this study: different cell lines were used in different experiments, which may induce inhomogeneity in the results. Then, we focused on the potential molecular mechanism of NEAT1 in LUAD. Previous studies have demonstrated that NEAT1 promoted tumor development by functioning as a ceRNA or a molecular sponge to bind to miRNA and subsequently regulate cancer-related gene expression [35] [36] [37] [38] . In this study, we probed the interaction between NEAT1 and miR-193a-3p. Bioinformatics analysis showed that NEAT1 harbored conserved miR-193a-3p cognate sites. Dual-luciferase reporter assay verified that miR-193a-3p directly targeted NEAT1 at its 3'-UTR. We further examined the expression of NEAT1 and miR-193a-3p in LUAD cells and normal lung epithelial cells. The results showed that NEAT1 was upregulated in LUAD cell lines (A549 and H1299) and miR-193a-3p was downregulated in LUAD cell lines (A549 and HCC827) compared with the normal lung cell line (BEAS-2B). However, the expression of NEAT1 in HCC827 cells was similar to that in BEAS-2B cells, and the expression of miR-193a-3p in H1299 cells was similar to that in BEAS-2B cells. Given the different genetic backgrounds of different cell lines, we conjecture that NEAT1 and miR-193a-3p are selectively expressed in different LUAD cell lines. Further study is necessary to corroborate these findings. Our research group has previously detected NEAT1 and miR-193a-3p expression in 125 NSCLC and adjacent non-tumorous lung samples by RT-qPCR, and we found high expression of NEAT1 and low expression of miR-193a-3p in NSCLC tissues [9, 39] . However, the expression levels of NEAT1 and miR-193a in LUAD tissues have not yet been separately elucidated. In this study, we combined the microarray and RNA-seq data from GEO, Oncomine, and TCGA and the in- house RT-qPCR data from our previous studies to systematically investigate the expression levels of NEAT1 and miR-193a-3p in LUAD. The pooled results showed that NEAT1 was upregulated while miR-193a-3p was downregulated in LUAD tissues. All of these findings indicated a targeted regulation of NEAT1 and miR-193a-3p. Numerous studies have demonstrated that miR-193a-3p plays vital roles in various cancers, including lung cancer. Yu et al [40] . detected miR-193a-3p expression in NSCLC and adjacent non-tumorous lung tissues. They found that miR193a-3p was downregulated in NSCLC tissues and that decreased miR-193a-3p was correlated with TNM stage as well as lymphatic metastasis. The authors also discovered that an enforced expression of miR-193a-3p restrained NSCLC metastasis in vitro and in vivo by negatively regulating the ERBB4/S6K2 signaling cascade. Similarly, Liang et al [41] . also demonstrated the target effect of miR-193a-3p on ERBB4 in NSCLC. A study carried out by Fan et al [42] . showed that miR-193a-3p has anti-tumor functions via negative modulation of its target KRAS. The interaction between miR-193a-3p and lncRNA has also been reported. A study conducted by Nie et al [43] . indicated that lncRNA UCA1 competitively sponged miR-193a-3p in NSCLC and thus increased the expression of ERBB4, a target of miR-193a-3p. In our study, we demonstrated that NEAT1 could directly bind to miR-193a-3p. To further explore whether NEAT1 acts as a ceRNA and antagonizes the inhibitory effect of miR-193a-3p on its target genes, we searched for putative target genes of miR-193a-3p in 12 online prediction databases and determined genes positively correlated with NEAT1 as candidate targets. Subsequently, we analyzed the expression of these selected genes with data from TCGA. The results showed that the USF1 gene was not only upregulated in LUAD, but also positively correlated with NEAT1. Hence, we hypothesized that NEAT1 may function as a ceRNA to sponge miR-193a-3p and relieve the inhibitory effect of miR-193a-3p on the USF1 gene. The potential regulatory mechanism is shown in Fig. 19 . Further in vitro and in vivo experiments are indispensable to validate our findings.
In summary, our results indicate that an overexpressed NEAT1 facilitates the occurrence and progression of LUAD. NEAT1 may exert its role by functioning as a ceRNA to regulate miR193a-3p. These findings provide a new perspective on the underlying molecular mechanism of NEAT1 in LUAD, suggesting that NEAT1 could be a valuable biomarker and therapeutic target in patients with LUAD. Fig. 19 . Underlying regulatory mechanism of NEAT1 in LUAD. NEAT1 may exert its role by functioning as a ceRNA to sponge miR-193a-3p and relieve the inhibitory effect of miR193a-3p on the USF1 gene. 
